Treatment of squamous cell carcinoma of the anal canal (SCCA): a new era?

There are no therapies available after progression on cisplatin and 5-FU that can improve survival for patients with squamous cell carcinoma of the anal canal (SCCA). Recently, two studies have been published [1, 2] that open the era of checkpoint inhibitors in SCCA.

http://ift.tt/2xwQ3CS